Novartis Capital CORP
SEC Filing List
CIK: 0001443411
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | NOVARTIS AG , Novartis Capital CORP | 03/17/2026 | ||
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | NOVARTIS AG , Novartis Capital CORP | 03/16/2026 | ||
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | NOVARTIS AG , Novartis Capital CORP | Toppan Merrill/fa | 11/04/2025 | |
| FWP | Filing under Securities Act Rules 163/43... | Novartis Capital Corp | Toppan Merrill/fa | 11/04/2025 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | NOVARTIS AG , Novartis Capital CORP | Toppan Merrill/fa | 11/03/2025 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | NOVARTIS AG , Novartis Capital CORP | Toppan Merrill/fa | 09/17/2024 | |
| F-3ASR | Automatic shelf registration statement o... | NOVARTIS AG , Novartis Capital CORP | Toppan Merrill/fa | 09/16/2024 | |
| FWP | Filing under Securities Act Rules 163/43... | Novartis Capital Corp | Toppan Merrill/fa | 09/16/2024 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | NOVARTIS AG , Novartis Capital CORP | Toppan Merrill/fa | 09/16/2024 | |
| POSASR | Post-effective Amendment to an automatic... | Merrill Corp /new/ - Fa /fa | 02/14/2020 | ||
| No record found. | |||||
| Load More | |||||